TBPH
#2558
Theravance Biopharma, Inc. - Ordinary Shares
16.9 0 USD
0.00%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.18%
Monthly Change
+1.75%
6 month change
-17.88%
Year Change
+17.77%
Previous Close
16.9 3
Open
16.9 0
Low
16.9 0
High
16.9 0
Volume
86
Financials
- Market Capitalization 871.25 M
- Employee 90
- Founded 2013
- CEO N/A
- Website www.theravance.com
- Headquarter California, United States
- FIGI N/A
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
9.08
Price to sales ratio
8.97
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2526 |  ANNX Annexon, Inc. - common stock | 5.63 USD | -2.93% | -6.01% | +17.29% | +114.07% | 922.43 M USD | ||
| 2535 |  GERN Geron Corporation - Common Stock | 1.42 USD | -5.33% | -1.39% | +22.41% | +6.77% | 910.96 M USD | ||
| 2559 |  PHAT Phathom Pharmaceuticals, Inc. - Common Stock | 10.92 USD | -13.40% | -5.37% | +5.81% | +20.80% | 870.94 M USD | ||
| 2561 |  DSGN Design Therapeutics, Inc. - Common Stock | 13.86 USD | -8.76% | -7.41% | +24.98% | +248.24% | 865.65 M USD |
Frequently asked questions about Theravance Biopharma, Inc. - Ordinary Shares
What is the Theravance Biopharma, Inc. - Ordinary Shares stock price today?
The current price of Theravance Biopharma, Inc. - Ordinary Shares (TBPH) is 16.9. Over the past 24 hours, the stock has changed by -0.18%. Follow the TBPH chart for real-time price dynamics.
What is the stock ticker of Theravance Biopharma, Inc. - Ordinary Shares?
Theravance Biopharma, Inc. - Ordinary Shares trades under the ticker TBPH. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Theravance Biopharma, Inc. - Ordinary Shares stock going up?
TBPH has changed by -0.59% over the last week, +1.75% over the last month, and +17.77% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Theravance Biopharma, Inc. - Ordinary Shares net income for the last quarter?
Theravance Biopharma, Inc. - Ordinary Shares reported net income of -4.93 M for the last quarter. The previous quarter showed 61.02 M, which means net income changed by -108.08%.
How many employees does Theravance Biopharma, Inc. - Ordinary Shares have?
As of the latest available data, Theravance Biopharma, Inc. - Ordinary Shares has 90 employees. Workforce size can provide additional context about the company's scale and operations.
What is Theravance Biopharma, Inc. - Ordinary Shares EBITDA?
Theravance Biopharma, Inc. - Ordinary Shares EBITDA is -9.1 M, and its EBITDA margin is -51.43%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Theravance Biopharma, Inc. - Ordinary Shares stock?
You can buy Theravance Biopharma, Inc. - Ordinary Shares (TBPH) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Theravance Biopharma, Inc. - Ordinary Shares stock?
Investing in Theravance Biopharma, Inc. - Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TBPH chart and related analysis on metatrader.com as part of your research.